Publicaciones en colaboración con investigadores/as de Red Espanola de Investigacion en Patologia Infecciosa (25)

2023

  1. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435

2021

  1. Dalbavancin for the treatment of prosthetic joint infections: A narrative review

    Antibiotics, Vol. 10, Núm. 6

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia

    BMC Infectious Diseases, Vol. 20, Núm. 1

  2. Correction to: Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia (BMC Infectious Diseases, (2020), 20, 1, (909), 10.1186/s12879-020-05534-1)

    BMC Infectious Diseases

2019

  1. Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study

    International Journal of Antimicrobial Agents, Vol. 53, Núm. 5, pp. 682-688

  2. Monitoring the antimicrobial susceptibility of gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the smart study (Spain, 2016 and 2017)

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 145-155

2018

  1. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among gram-negative organisms recovered during the SMART study in Spain (2011-2015)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 136-145

  2. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

    Medical Mycology, Vol. 56, Núm. 7, pp. 903-906

  3. Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 3

2017

  1. In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

2016

  1. Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 8, pp. 2131-2138

2014

  1. Diagnosis of venous access port colonization requires cultures from multiple sites: Should guidelines be amended?

    Diagnostic Microbiology and Infectious Disease, Vol. 78, Núm. 2, pp. 162-167

2013

  1. Bloodstream infections in patients with kidney disease: Risk factors for poor outcome and mortality

    Journal of Hospital Infection, Vol. 85, Núm. 3, pp. 196-205

  2. Can microbiologists help to assess catheter involvement in candidaemic patients before removal?

    Clinical Microbiology and Infection, Vol. 19, Núm. 2

  3. Catheter-related bloodstream infection caused by Enterococcus spp.

    Clinical Microbiology and Infection, Vol. 19, Núm. 5, pp. 457-461

  4. Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients

    Intensive Care Medicine, Vol. 39, Núm. 9, pp. 1547-1555

  5. Targeted antifungal prophylaxis in heart transplant recipients

    Transplantation, Vol. 96, Núm. 7, pp. 664-669

  6. Value of matrix-assisted laser desorption ionization-time of flight for routine identification of viridans group streptococci causing bloodstream infections

    Clinical Microbiology and Infection, Vol. 19, Núm. 5, pp. 438-444

2012

  1. Differential time to positivity (DTTP) for the diagnosis of catheter-related bloodstream infection: Do we need to obtain one or more peripheral vein blood cultures?

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 7, pp. 1367-1372